Expanding Patient Access to Buprenorphine for Opioid Use Disorder Through Pharmacist Independent Prescriptive Authority
- DOI
- 10.1177/29767342261467580
- Published
- 2026-07-19
- Container
- Substance Use & Addiction Journal
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/29767342261467580,
title = {Expanding Patient Access to Buprenorphine for Opioid Use Disorder Through Pharmacist Independent Prescriptive Authority},
author = {Michelle D. Colvard and Terri L. Jorgenson and Veldana Alliu and Tera D. Moore and Haley E. Pals and Jacob D. Baylis and Michael Tran and Roisin M. Sabol and Adam J. Gordon},
year = {2026},
journal = {Substance Use \& Addiction Journal},
doi = {10.1177/29767342261467580},
url = {https://doi.org/10.1177/29767342261467580}
}RIS
TY - JOUR TI - Expanding Patient Access to Buprenorphine for Opioid Use Disorder Through Pharmacist Independent Prescriptive Authority AU - Michelle D. Colvard AU - Terri L. Jorgenson AU - Veldana Alliu AU - Tera D. Moore AU - Haley E. Pals AU - Jacob D. Baylis AU - Michael Tran AU - Roisin M. Sabol AU - Adam J. Gordon PY - 2026 JO - Substance Use & Addiction Journal DO - 10.1177/29767342261467580 UR - https://doi.org/10.1177/29767342261467580 ER -
APA
Colvard, M. D., Jorgenson, T. L., Alliu, V., Moore, T. D., Pals, H. E., Baylis, J. D., Tran, M., Sabol, R. M., & Gordon, A. J. (2026). Expanding Patient Access to Buprenorphine for Opioid Use Disorder Through Pharmacist Independent Prescriptive Authority. Substance Use & Addiction Journal. https://doi.org/10.1177/29767342261467580
Source records
- crossref · retrieved 2026-09-25T13:54:26.630Z